Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-23-000017
Filing Date
2023-08-03
Accepted
2023-08-03 08:34:49
Documents
46
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20230630.htm   iXBRL 10-Q 660473
2 EX-31.1 exhibit311q223.htm EX-31.1 8860
3 EX-31.2 exhibit312q223.htm EX-31.2 8955
4 EX-32.1 exhibit321q223.htm EX-32.1 5138
5 EX-32.2 exhibit322q223.htm EX-32.2 5295
11 GRAPHIC vrna-20230630_g1.jpg GRAPHIC 182762
  Complete submission text file 0001657312-23-000017.txt   3363584

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230630.xsd EX-101.SCH 21785
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20230630_cal.xml EX-101.CAL 41996
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20230630_def.xml EX-101.DEF 59442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230630_lab.xml EX-101.LAB 299138
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230630_pre.xml EX-101.PRE 174812
40 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230630_htm.xml XML 259837
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 231138250
SIC: 2834 Pharmaceutical Preparations